Nausea rates sit at 24%, vomiting at 13%, and diarrhea at 21%
L-Glutathione cannot be properly synthesized in people with liver disorders such as liver cancer, hepatitis, etc
Side effects of retatrutide The most frequently reported side effects associated with retatrutide treatment are gastrointestinal, including nausea, vomiting, diarrhoea, and constipation
it makes them more predictable and time-limited
Kaufmans fear is that both trials will fail because too many patients will suffer side effects and withdraw, and the drug will be forever lost to vast majority of long-COVID patients
(1998) is published in the European Journal of Endocrinology